DIANE EAKINS: Open Payments
NPI 1841765872 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,486 in 65 payments from 13 companies in 2025. Trend: 2023 $1,550 · 2024 $1,758 · 2025 $1,486
Food & beverage: $1,486
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 20 | $436 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $360 |
| E.R. Squibb & Sons, L.L.C. | 4 | $198 |
| Corium, LLC | 8 | $124 |
| Neurocrine BioSciences, Inc. | 4 | $101 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| ABBVIE INC. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| Tris Pharma Inc | 2 | $30 |
| Lundbeck LLC | 1 | $26 |
Products named: REXULTI, CAPLYTA, COBENFY, Azstarys, INGREZZA, SPRAVATO, VRAYLAR, Auvelity.
Industry payments across TX — which companies pay providers there.
